Clinical Infectious Diseases · 1997 · 53 citations · 10 references
Life SciencesInfectious DiseasesMicrobiologyAntimicrobial ResistanceMedical MicrobiologyTuberculosis ControlAcquired ResistanceAntibiotic ResistanceAntiretroviral TherapyPulmonary TuberculosisTuberculosis CareTuberculosis EpidemiologyDrug Resistance TestingHuman Immunodeficiency Virus-associated TuberculosisMolecular Drug ResistanceMolecular Drug Susceptibility TestingMycobacterium Tuberculosis InfectionPhenotypic Drug Susceptibility TestingRifampicin Resistance TestingTuberculosis Drug Resistance
We describe five compliant patients with human immunodeficiency virus (HIV)-associated tuberculosis (TB) that relapsed, with acquisition of resistance by the original Mycobacterium tuberculosis strains. Both the first and second isolates from each patient had the same IS (insertion sequence) 6110-based DNA fingerprint patterns. Three of the five patients developed TB that was resistant to rifampin alone; no mutation in the region of the rpoB gene was detected by a line probe assay in two of the isolates from these patients. We discuss several factors presumably associated with acquired drug resistance in HIV-infected patients, including exogenous reinfection, drug interactions, malabsorption of drugs, and the presence of a large organism burden.
10